Digitalis Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical DevicesAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)Jayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.
BiotechHealthtechMedical DevicesSan Diego, US
Linda Black(Chief Executive Officer, Chief Financial Officer & Secretary)Aaron Hirschhorn(Executive Officer, Director)Davis Brimer(Executive Officer, Director)
BoardTeymour Boutros-Ghali(Director)Valentine Williams(DVM, MS, Diplomate ACVS)Aaron Schacht(Director)
Board seatMisti Ushio· per SEC Form D · $18M raise · filed Jul 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.